GSK, TCS to Jointly Set Up Drug Development Center

by VR Sreeraman on  March 28, 2007 at 3:00 PM Corporate News
RSS Email Print This Page Comment bookmark
Font : A-A+

GSK, TCS to Jointly Set Up Drug Development Center
Pharma major GlaxoSmithKline (GSK) and global IT giant Tata Consultancy Services (TCS) have entered into a multi-million dollar contract for setting up a global drug development center in Mumbai.

Under the contract, TCS will provide a variety of services in clinical research, including clinical data management and clinical submissions support.

"GSK has chosen to partner with TCS because of its strong record in knowledge process outsourcing, underpinned by operational excellence," Amber Salzman, senior vice president, development operations, GSK, said in a statement Tuesday.

According to Salzman, the partnership will also help deliver new medicines to patients.

GSK, under this alliance, also plans to expand capacity in response to increased efficiency demands, leverage the high-quality talent pool in India, and benefit from cost and process improvements.

Source: IANS
SRM

Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
Notify me when reply is posted
I agree to the terms and conditions

More News on:

Drug Toxicity Signature Drug Toxicity 

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook

News Category

News Archive